About Joshua Brown
Joshua Brown joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2016. He was promoted with tenure to associate professor in 2022. He is experienced in clinical pharmacy, health economics and outcomes research, and pharmacoepidemiology across the academic, pharmaceutical industry, and managed care fields. His current research program and collaborations focus on research methods for pharmacoepidemiologic and pharmacoeconomic generic and biosimilar evaluations, developing real-world evidence for drug-drug interactions, and conducting translational research in aging and aging-related diseases. His academic work has been funded by the NIH, FDA, Bill & Melinda Gates Foundation, and the PhRMA Foundation.
Joshua has published over 120 papers and holds several editorial positions with high-impact specialty journals in pharmacy and cardiovascular diseases. He is actively involved in AMCP, ISPE, and ISPOR scientific societies. Dr. Brown was awarded as the AMCP Foundation’s “New Practitioner” for his early career contributions to managed care pharmacy. Dr. Brown is the faculty advisor of UF’s AMCP student chapter and has mentored over 20 graduate and pharmacy students in research.
University of Florida College of Pharmacy researchers studying the safety of two classes of drugs touted as potential therapeutics for COVID-19 report mixed results.
UF Faculty and alumni took over several leadership roles in the society during the 35th International Conference on Pharmacoepidemiology in Philadelphia. Along with Dr. Almut Winterstein, Dr. Juan Hincapie-Castillo also…
UF researchers reviewed more than 13 million patients using carisoprodol, a powerful muscle relaxant.
AMCP gives the award to a member who has made a significant contribution to managed care pharmacy within five years of graduation.